Evidence map›Paper›PMID 23075270›Full record

ArticleMolecular microbiology2012

sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates.

Agnieszka K Zielinska, Karen E Beenken, Lara N Mrak, Horace J Spencer, Ginell R Post, Robert A Skinner, Alan J Tackett, Alexander R Horswill, Mark S Smeltzer

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 115 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  5. The Pathogenicity Mechanisms ofInternational journal of molecular sciences · 2025
    Review
  6. Calprotectin protectsmSystems · 2025
    Article
  7. Article
  8. Article
  9. Cell surface (Amsterdam, Netherlands) · 2025
    Review
  10. Microorganisms · 2025
    Review
  11. The ability ofInfection and immunity · 2025
    Article
  12. Article
  13. DNA and cell biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Draft genome sequence of a highly proteolyticMicrobiology resource announcements · 2023
    Article
  19. Article
  20. The major role ofVirulence · 2023
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Agnieszka K ZielinskaDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Karen E Beenken
Lara N Mrak
Horace J Spencer
Ginell R Post
Robert A Skinner
Alan J Tackett
Alexander R Horswill
Mark S Smeltzer
University of Arkansas for Medical Sciences · USUniversity of Iowa · US

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Stephanie Diane Hayes · 2012 to 2026
$60.9M
Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
SAR-MEDIATED REGULATION IN STAPHYLOCOCCUS AUREUSR01AI043356 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 1998 to 2008
$2.0M
Quorum sensing-dependent interactions with biofilms and innate immunity defensesR01AI078921 · NIAID · UNIVERSITY OF IOWA · PI HORSWILL, ALEXANDER R · 2008 to 2012
$2.0M
Detection, diagnosis and treatment of musculoskeletal infectionR01AI069087 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2007 to 2011
$1.7M
Development of technology for high resolution epigenetic profiling of chromatinR01DA025755 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN, TAVERNA, SEAN D. · 2008 to 2011
$1.6M
Regulation of biofilm formation in clinical isolates of Staphylococcus aureusR01AI074935 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2007 to 2011
$1.6M
A nanotherapeutic approach to combat staphylococcal biofilm-associated infectionR56AI093126 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2011 to 2011
$360k
NCRR NIH HHS RR0298884NIAID NIH HHS AI069087NIAID NIH HHS AI093126NIAID NIH HHS R01 AI043356NIAID NIH HHS R01 AI069087NIAID NIH HHS R01 AI074935NIAID NIH HHS R01 AI078921NIAID NIH HHS R56 AI093126NIDA NIH HHS R01 DA025755NIDA NIH HHS R01DA025755NIGMS NIH HHS P20 GM103429NIGMS NIH HHS P20GM103429NIGMS NIH HHS P30 GM103450NIGMS NIH HHS P30GM103450
6 · The paper itself

Abstract

Mutation of staphylococcal accessory regulator (sarA) results in increased production of extracellular proteases in Staphylococcus aureus, which has been correlated with decreased biofilm formation and decreased accumulation of extracellular toxins. We used murine models of implant-associated biofilm infection and S. aureus bacteraemia (SAB) to compare virulence of USA300 strain LAC, its isogenic sarA mutant, and derivatives of each of these strains with mutations in all 10 of the genes encoding recognized extracellular proteases. The sarA mutant was attenuated in both models, and this was reversed by eliminating production of extracellular proteases. To examine the mechanistic basis, we identified proteins impacted by sarA in a protease-dependent manner. We identified 253 proteins where accumulation was reduced in the sarA mutant compared with the parent strain, and was restored in the sarA/protease mutant. Additionally, in SAB, the LAC protease mutant exhibited a hypervirulent phenotype by comparison with the isogenic parent strain, demonstrating that sarA also positively regulates production of virulence factors, some of which are subject to protease-mediated degradation. We propose a model in which attenuation of sarA mutants is defined by their inability to produce critical factors and simultaneously repress production of extracellular proteases that would otherwise limit accumulation of virulence factors.

Indexed as

Gene Expression Regulation, BacterialAnimalsAnimals, Outbred StrainsAnti-Bacterial AgentsBacteremiaBacterial ProteinsBiofilmsCatheter-Related InfectionsDaptomycinDisease Models, AnimalFemaleHumansMiceMicrobial Sensitivity TestsPeptide HydrolasesStaphylococcal InfectionsAnti-Bacterial AgentsBacterial ProteinsDaptomycinPeptide HydrolasesSarA protein, Staphylococcus aureusVirulence Factors

Identifiers

PMID23075270
PMCPMC3508076
OpenAlexW1572163329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.